Table 7.
Antimicrobial susceptibility (percentage) of non-Enterobacteriaceae Gram-negative isolates causing bloodstream infection
| Antimicrobial | P. aeruginosa | Acinetobacterspp. | Other* | Total | ||||
| CA 7 | HA 6 | CA 3 | HA 9 | CA 6 | HA 5 | CA 16 | HA 20 | |
| Ampicillin | 0 | 0 | 0 | 0 | 17 | 0 | 7 | 0 |
| Amoxicillin-clavulanate | 17 | 20 | 67 | 33 | 67 | 0 | 47 | 22 |
| Cefuroxime | 20 | 0 | 67 | 22 | 67 | 25 | 50 | 17 |
| Ceftazidime | 100 | 100 | 67 | 78 | 83 | 50 | 88 | 79 |
| Meropenem | 100 | 100 | 100 | 100 | 50 | 50 | 85 | 88 |
| Gentamicin | 86 | 83 | 33 | 56 | 50 | 50 | 63 | 63 |
| Tobramicin | 86 | 100 | - | - | - | - | - | - |
| Doxycycline | 0 | 0 | 67 | 56 | 100 | 50 | 54 | 47 |
| Co-trimoxazole | 0 | 0 | 0 | 0 | 33 | 50 | 14 | 13 |
| Chloramphenicol | 20 | 0 | 33 | 22 | 67 | 0 | 43 | 13 |
| Ciprofloxacin | 100 | 100 | 100 | 78 | 100 | 100 | 100 | 89 |
CA, community-acquired infection; HA, hospital-acquired infection; "-", not done. *Other isolates include other Pseudomonas spp., (5), Sphingomonas paucimobilis (2), Chryseobacterium spp. (2), Moraxella spp. (2).